Effect of Hydrogen Gas on Hyperbaric Oxygen Toxicity
2 other identifiers
interventional
32
1 country
2
Brief Summary
The goal of this trial is to investigate whether adding a small fraction of hydrogen gas to an oxygen-enriched breathing mixture can reduce pulmonary oxygen toxicity (POT) in healthy and active divers from the Swedish Armed Forces. The main questions it aims to answer are:
- Does hydrogen gas reduce oxidative stress and changes in pulmonary function associated with prolonged hyperbaric oxygen exposure?
- What are the underlying pathophysiological mechanisms of pulmonary oxygen toxicity? Researchers will compare oxygen-enriched breathing gas with 1-2% hydrogen to oxygen-enriched gas with 1-2% nitrogen (control) to see if hydrogen provides protective effects against POT during hyperbaric exposure. Participants will:
- Complete two hyperbaric exposure sessions (hydrogen vs. nitrogen), each lasting 240 minutes at 1.75 ATA
- Undergo pulmonary function tests and sampling of blod and urin before and after each session
- Serve as their own controls in a double-blind, randomized, crossover study design
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2025
CompletedFirst Posted
Study publicly available on registry
December 4, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
December 4, 2025
December 1, 2025
3.9 years
September 29, 2025
December 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Vital Capacity (ΔVC)
Absolute change in vital capacity (VC), calculated as the difference in liters (L) between pre-exposure and post-exposure spirometry values, measured after each hyperbaric oxygen exposure session.
Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.
Secondary Outcomes (15)
Forced Expiratory Volume in One Second (FEV₁)
Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure
Change in FEV₁/FVC ratio
Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure
Change in Forced Expiratory Flow 25-75% (FEF25-75%)
Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.
Change in Peak Expiratory Flow (PEF)
Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.
Change in Inspiratory Capacity (IC)
Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.
- +10 more secondary outcomes
Other Outcomes (1)
Anthropometric Measurements (Weight, Height, Sex, Age, BMI)
Baseline (Pre-exposure, prior to first dive session)
Study Arms (2)
Hydrogen Gas Intervention
EXPERIMENTALIn this arm, participants will undergo a single hyperbaric exposure breathing a gas mixture composed of 98-99% oxygen and 1-2% hydrogen (H₂) at a partial pressure of 1.75 ATA for 240 minutes. The intervention aims to evaluate whether hydrogen gas has protective effects against pulmonary oxygen toxicity. Pulmonary function tests and blood and urin sampling for oxidative stress biomarkers will be performed both before and after the exposure session. The order of intervention and control exposures is randomized and the study is conducted in a double-blind fashion. A washout period of at least two weeks will follow before the control
Nitrogen Gas Control
ACTIVE COMPARATORIn this arm, participants will undergo a single hyperbaric exposure breathing a gas mixture composed of 98-99% oxygen and 1-2% nitrogen (N₂) at a partial pressure of 1.75 ATA for 240 minutes. This exposure serves as the control condition and represents the standard oxygen-enriched breathing gas currently in use. Pulmonary function tests and blood and urin sampling for oxidative stress biomarkers will be performed both before and after the exposure session. Participants will be randomized to the order of exposures, and both participants and investigators will be blinded to the gas composition. A washout period of at least two weeks will follow before the intervention.
Interventions
Participants will inhale a gas mixture consisting of 98-99% oxygen and 1-2% hydrogen via a breathing circuit during a single hyperbaric exposure. The exposure will be conducted at a partial pressure of 1.75 ATA for 240 minutes. The intervention aims to evaluate the protective effect of hydrogen gas against pulmonary oxygen toxicity.
Participants will inhale a gas mixture consisting of 98-99% oxygen and 1-2% nitrogen via a breathing circuit during a single hyperbaric exposure. The exposure will be conducted at a partial pressure of 1.75 ATA for 240 minutes. The intervention aims to evaluate the protective effect of hydrogen gas against pulmonary oxygen toxicity.
Eligibility Criteria
You may qualify if:
- Military divers actively serving, aged 20-64 years
- Meeting the Swedish Armed Forces physical standards for diving
You may not qualify if:
- Ongoing infection or illness that may impact pulmonary function
- Use of alcohol or smoking cigarettes within 48 hours
- Diving with any breathing gas within 48 hours
- Diving with oxygen-enriched gas (100% O₂) within 2 weeks
- Use of medications that could affect oxidative stress, lung function, or neurological status
- Medical history of serious diving-related injuries or long-term complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Blekinge Institute of Technologylead
- Karolinska Institutetcollaborator
- Göteborg Universitycollaborator
- Lund Universitycollaborator
- Swedish Armed Forces Diving and Naval Medicine Centrecollaborator
Study Sites (2)
Blekinge Institute of Technology
Karlskrona, Blekinge County, 37179, Sweden
Swedish Armed Forces Diving and Naval Medicine Centre (DNC)
Karlskrona, Sweden
Related Publications (4)
de Jong FJM, Wingelaar TT, van Hulst RA. Pulmonary oxygen toxicity in occupational diving. Occup Med (Lond). 2023 Jun 26;73(5):231-232. doi: 10.1093/occmed/kqad043.
PMID: 37364027RESULTKawamura T, Wakabayashi N, Shigemura N, Huang CS, Masutani K, Tanaka Y, Noda K, Peng X, Takahashi T, Billiar TR, Okumura M, Toyoda Y, Kensler TW, Nakao A. Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo. Am J Physiol Lung Cell Mol Physiol. 2013 May 15;304(10):L646-56. doi: 10.1152/ajplung.00164.2012. Epub 2013 Mar 8.
PMID: 23475767RESULTYildiz F, LeBaron TW, Alwazeer D. A comprehensive review of molecular hydrogen as a novel nutrition therapy in relieving oxidative stress and diseases: Mechanisms and perspectives. Biochem Biophys Rep. 2025 Jan 25;41:101933. doi: 10.1016/j.bbrep.2025.101933. eCollection 2025 Mar.
PMID: 39911528RESULTOhsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007 Jun;13(6):688-94. doi: 10.1038/nm1577. Epub 2007 May 7.
PMID: 17486089RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2025
First Posted
December 4, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
December 1, 2029
Study Completion (Estimated)
December 1, 2030
Last Updated
December 4, 2025
Record last verified: 2025-12